Published in Int Immunol on April 07, 2008
Early life activation of toll-like receptor 4 reprograms neural anti-inflammatory pathways. J Neurosci (2010) 1.03
A critical role for MAPK signalling pathways in the transcriptional regulation of toll like receptors. PLoS One (2013) 1.02
Altered innate immune response of plasmacytoid dendritic cells in multiple sclerosis. Clin Exp Immunol (2009) 0.93
Expression and functional analysis of toll-like receptors of peripheral blood cells in asthmatic patients: implication for immunopathological mechanism in asthma. J Clin Immunol (2008) 0.91
Pattern recognition receptor expression is not impaired in patients with chronic mucocutanous candidiasis with or without autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. Clin Exp Immunol (2009) 0.89
Stimulation of TLR7 prior to polymicrobial sepsis improves the immune control of the inflammatory response in adult mice. Inflamm Res (2010) 0.82
Novel Immunomodulatory Flagellin-Like Protein FlaC in Campylobacter jejuni and Other Campylobacterales. mSphere (2015) 0.76
Toll-like receptors in pathophysiology of liver diseases. World J Hepatol (2016) 0.75
Murine J774 macrophages recognize LPS/IFN-g, non-CpG DNA or two-CpG DNA-containing sequences as immunologically distinct. Nitric Oxide (2010) 0.75
Role of HER2 in wound-induced breast carcinoma proliferation. Lancet (2003) 3.40
FOXP3 expression and overall survival in breast cancer. J Clin Oncol (2009) 2.71
Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy. Blood (2009) 1.88
Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology (2008) 1.62
HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer. J Clin Oncol (2003) 1.61
Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. Cancer Res (2008) 1.61
Apoptosis induction by trastuzumab: possible role of the core biopsy intervention. J Clin Oncol (2005) 1.49
DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization. J Nucl Med (2008) 1.49
Combination of metronomic gimatecan and CpG-oligodeoxynucleotides against an orthotopic pancreatic cancer xenograft. Cancer Biol Ther (2008) 1.47
Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection. Genome Biol (2007) 1.38
Degranulation of paneth cells via toll-like receptor 9. Am J Pathol (2004) 1.36
Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia. J Histochem Cytochem (2009) 1.29
Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer. J Immunol (2006) 1.26
Conservation of genetic alterations in recurrent melanoma supports the melanoma stem cell hypothesis. Cancer Res (2008) 1.22
Molecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsets. J Transl Med (2006) 1.21
Activation of enteroendocrine cells via TLRs induces hormone, chemokine, and defensin secretion. J Immunol (2007) 1.15
Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of beta-defensin 2 via TLR2 and TLR4. J Immunol (2008) 1.14
CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma. Cancer Res (2008) 1.14
Development of ligands for the peripheral benzodiazepine receptor. Curr Med Chem (2006) 1.13
Activation of smooth muscle and myenteric plexus cells of jejunum via Toll-like receptor 4. J Cell Physiol (2006) 1.13
The product of X-linked Kallmann's syndrome gene (KAL1) affects the migratory activity of gonadotropin-releasing hormone (GnRH)-producing neurons. Hum Mol Genet (2004) 1.09
Genomic scale analysis of racial impact on response to IFN-alpha. Proc Natl Acad Sci U S A (2009) 1.08
CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects. J Transl Med (2007) 1.06
Critical role of TLR9 in acute graft-versus-host disease. J Immunol (2008) 1.03
Novel pathogenic mechanisms of congenital insensitivity to pain with anhidrosis genetic disorder unveiled by functional analysis of neurotrophic tyrosine receptor kinase type 1/nerve growth factor receptor mutations. J Biol Chem (2001) 1.03
Proximity of TPR and NTRK1 rearranging loci in human thyrocytes. Cancer Res (2005) 1.01
HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviors. Clin Cancer Res (2002) 1.00
TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects. Cancer Res (2011) 1.00
HER2 as a target for breast cancer therapy. Expert Opin Biol Ther (2010) 0.99
Synthesis of new pyrazolo[5,1-c][1,2,4] benzotriazines, pyrazolo[5,1-c]pyrido[4,3-e][1,2,4] triazines and their open analogues as cytotoxic agents in normoxic and hypoxic conditions. Bioorg Med Chem (2008) 0.98
Helper B cells promote cytotoxic T cell survival and proliferation independently of antigen presentation through CD27/CD70 interactions. J Immunol (2008) 0.97
CpG-oligodeoxynucleotides induce mobilization of hematopoietic progenitor cells into peripheral blood in association with mouse KC (IL-8) production. J Cell Physiol (2005) 0.97
FOXP3 expression in tumor cells and implications for cancer progression. J Cell Physiol (2013) 0.95
Induction of Paneth cell degranulation by orally administered Toll-like receptor ligands. J Cell Physiol (2012) 0.93
Eradication of ovarian tumor xenografts by locoregional administration of targeted immunotherapy. Clin Cancer Res (2008) 0.93
Expression profile of tyrosine phosphatases in HER2 breast cancer cells and tumors. Cell Oncol (2010) 0.93
Therapeutic synergism of gemcitabine and CpG-oligodeoxynucleotides in an orthotopic human pancreatic carcinoma xenograft. Cancer Res (2005) 0.93
Therapeutic efficacy of cord blood-derived mesenchymal stromal cells for the prevention of acute graft-versus-host disease in a xenogenic mouse model. Stem Cells Dev (2011) 0.91
Benzodiazepine receptor ligands. 8: synthesis and pharmacological evaluation of new pyrazolo[5,1-c] [1,2,4]benzotriazine 5-oxide 3- and 8-disubstituted: high affinity ligands endowed with inverse-agonist pharmacological efficacy. Bioorg Med Chem (2005) 0.91
Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses. J Leukoc Biol (2007) 0.91
Activity and resistance of trastuzumab according to different clinical settings. Cancer Treat Rev (2011) 0.90
Low dose oral administration of cytokines for treatment of allergic asthma. Pulm Pharmacol Ther (2009) 0.89
Role of proliferation in HER2 status predicted response to doxorubicin. Int J Cancer (2003) 0.89
Influence of antibiotic treatment on breast carcinoma development in proto-neu transgenic mice. Cancer Res (2006) 0.88
Induction of pro-inflammatory programs in enteroendocrine cells by the Toll-like receptor agonists flagellin and bacterial LPS. Int Immunol (2008) 0.86
Associations between HLA class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among Tunisians. J Transl Med (2007) 0.86
GM-CSF/IL-3/IL-5 receptor common beta chain (CD131) expression as a biomarker of antigen-stimulated CD8+ T cells. J Transl Med (2008) 0.86
Desmoglein 3 and keratin 10 expressions are reduced by chronic exposure to cigarette smoke in human keratinised oral mucosa explants. Arch Oral Biol (2010) 0.86
Absence of the CD1 molecule up-regulates antitumor activity induced by CpG oligodeoxynucleotides in mice. J Immunol (2002) 0.86
High efficacy of CpG-ODN, cetuximab and cisplatin combination for very advanced ovarian xenograft tumors. J Transl Med (2013) 0.85
Spontaneous and treatment-induced cancer rejection in humans. Expert Opin Biol Ther (2008) 0.85
Stimulation of TLRs by LMW-HA induces self-defense mechanisms in vaginal epithelium. Immunol Cell Biol (2010) 0.85
Sodium-dependent glucose transporter-1 as a novel immunological player in the intestinal mucosa. J Immunol (2008) 0.85
Doxorubicin-induced alopecia is associated with sebaceous gland degeneration. J Invest Dermatol (2006) 0.85
Raman and SERS recognition of β-carotene and haemoglobin fingerprints in human whole blood. Spectrochim Acta A Mol Biomol Spectrosc (2011) 0.84
A double-blind, randomised, vehicle-controlled clinical study to evaluate the efficacy of MAS065D in limiting the effects of radiation on the skin: interim analysis. Eur J Dermatol (2008) 0.83
Ascites regression and survival increase in mice bearing advanced-stage human ovarian carcinomas and repeatedly treated intraperitoneally with CpG-ODN. J Immunother (2010) 0.82
Intestinal glucose uptake protects liver from lipopolysaccharide and D-galactosamine, acetaminophen, and alpha-amanitin in mice. Am J Pathol (2009) 0.82
Novel 3-iodo-8-ethoxypyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide as promising lead for design of alpha5-inverse agonist useful tools for therapy of mnemonic damage. Bioorg Med Chem (2007) 0.82
Receptor tyrosine kinase pathway analysis sheds light on similarities between clear-cell sarcoma and metastatic melanoma. Genes Chromosomes Cancer (2011) 0.82
Thymic function and immunoglobulin mutation genotype in B-cell chronic lymphocytic leukemia patients. Int J Cancer (2003) 0.82
Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO). Bioorg Med Chem Lett (2010) 0.81
Maspin influences response to doxorubicin by changing the tumor microenvironment organization. Int J Cancer (2013) 0.81
Antitumor efficacy of trastuzumab in nude mice orthotopically xenografted with human pancreatic tumor cells expressing low levels of HER-2/neu. J Immunother (2008) 0.81
Comprehensive epitope mapping of the Epstein-Barr virus latent membrane protein-2 in normal, non tumor-bearing individuals. Cancer Immunol Immunother (2006) 0.80
Caseinphosphopeptide-induced calcium uptake in human intestinal cell lines HT-29 and Caco2 is correlated to cellular differentiation. J Nutr Biochem (2009) 0.80
Desmocollin 1 and desmoglein 1 expression in human epidermis and keratinizing oral mucosa: a comparative immunohistochemical and molecular study. Arch Dermatol Res (2005) 0.80